Boothbay Fund Management’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-801,781
Closed -$48.1K 2052
2023
Q4
$48.1K Sell
801,781
-219
-0% -$12 ﹤0.01% 1527
2023
Q3
$46.5K Hold
802,000
﹤0.01% 1633
2023
Q2
$46K Hold
802,000
﹤0.01% 1677
2023
Q1
$40.1K Hold
802,000
﹤0.01% 2035
2022
Q4
$105K Sell
802,000
-10,378
-1% -$1.3K ﹤0.01% 1775
2022
Q3
$97K Hold
812,378
﹤0.01% 2050
2022
Q2
$65K Hold
812,378
﹤0.01% 2051
2022
Q1
$98K Hold
812,378
﹤0.01% 2108
2021
Q4
$149K Hold
812,378
﹤0.01% 1605
2021
Q3
$158K Hold
812,378
﹤0.01% 1652
2021
Q2
$219K Buy
812,378
+9,553
+1% +$1.97K 0.01% 1466
2021
Q1
$145K Buy
+802,825
New +$187K 0.01% 1428

Other funds holding VHAQ.RT

Boothbay Fund Management's VHAQ.RT Position: Q1 2024 in Review

Boothbay Fund Management sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 801,781 shares — an estimated $48.1K sold.

Boothbay Fund Management first reported a position in VHAQ.RT in Q1 2021 and held it in 12 quarters. The position peaked at $219K in Q2 2021. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Boothbay Fund Management reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 801,781 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $48.1K.
  • Boothbay Fund Management first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2021 and held it in 12 quarters.
  • Boothbay Fund Management's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $219K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.